These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

472 related articles for article (PubMed ID: 3028785)

  • 1. Further biochemical characterization of an Na+ pump inhibitor purified from human urine.
    Crabos M; Grichois ML; Guicheney P; Wainer IW; Cloix JF
    Eur J Biochem; 1987 Jan; 162(1):129-35. PubMed ID: 3028785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endogenous Na+ transport inhibitor in human hypertension: further biochemical and chemical studies.
    Cloix JF; Crabos M; Grichois ML; Guicheney P; Meyer P
    Klin Wochenschr; 1987; 65 Suppl 8():146-53. PubMed ID: 3037183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An endogenous digitalis-like compound extracted from human urine: biochemical and chemical studies.
    Cloix JF; Crabos M; Grichois ML; Meyer P
    Can J Physiol Pharmacol; 1987 Aug; 65(8):1522-7. PubMed ID: 2825938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sodium pump inhibition and regional expression of sodium pump alpha-isoforms in lens.
    Tao QF; Hollenberg NK; Graves SW
    Hypertension; 1999 Nov; 34(5):1168-74. PubMed ID: 10567200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purification and characterization of human urine-derived digitalis-like factor.
    Goto A; Yamada K; Ishii M; Yoshioka M; Ishiguro T; Eguchi C; Sugimoto T
    Biochem Biophys Res Commun; 1988 Aug; 154(3):847-53. PubMed ID: 2841934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endogenous inhibitors of the Na+, K(+)-pump and platelet Ca2+ handling in hypertension.
    Devynck MA; David-Dufilho M; Astarie C; Mazeaud M; Pernollet MG; Le Quan Sang KH
    Physiol Bohemoslov; 1990; 39(1):71-8. PubMed ID: 2165268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ouabainlike factor in Milan hypertensive rats.
    Ferrandi M; Minotti E; Salardi S; Florio M; Bianchi G; Ferrari P
    Am J Physiol; 1992 Oct; 263(4 Pt 2):F739-48. PubMed ID: 1329560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endogenous plasma Na,K-ATPase inhibitory activity and digoxin like immunoreactivity after acute myocardial infarction.
    Bagrov AYa ; Fedorova OV; Maslova MN; Roukoyatkina NI; Ukhanova MV; Zhabko EP
    Cardiovasc Res; 1991 May; 25(5):371-7. PubMed ID: 1649699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positive inotropic effects of the endogenous Na+/K(+)-transporting ATPase inhibitor from the hypothalamus.
    Hallaq HA; Haupert GT
    Proc Natl Acad Sci U S A; 1989 Dec; 86(24):10080-4. PubMed ID: 2557617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemical and clinical studies of endogenous digitalis-like factor in hypertension.
    Cloix JF; Devynck MA; Meyer P
    Ann N Y Acad Sci; 1986; 488():217-27. PubMed ID: 2437846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding of ouabain and human ouabainlike substance to different Na+, K+-ATPase isoforms.
    Butt AN; Tennant BP; Gillingwater SD; Shepherd PS; Swaminathan R
    Hypertens Res; 2000 Sep; 23 Suppl():S45-50. PubMed ID: 11016819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of human urine-derived digitalis-like factor on cultured renal tubular epithelial cells.
    Goto A; Yamada K; Ishii M; Yoshioka M; Ishiguro T; Eguchi C; Sugimoto T
    J Hypertens Suppl; 1988 Dec; 6(4):S287-9. PubMed ID: 2853736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sodium pump isoform specificity for the digitalis-like factor isolated from human peritoneal dialysate.
    Tao QF; Hollenberg NK; Price DA; Graves SW
    Hypertension; 1997 Mar; 29(3):815-21. PubMed ID: 9052901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of endogenous digoxin-like factor and digoxin antibody on myocardial Na+, K(+)-pump activity and ventricular arrhythmias in acute myocardial ischaemia in rats.
    Bagrov AY; Fedorova OV; Roukoyatkina NI; Zhabko EP
    Cardiovasc Res; 1993 Jun; 27(6):1045-50. PubMed ID: 8221762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Inhibitory action of peruvoside and neriifolin on Na+, K(+)-ATPase].
    Ye YX; Yang XR
    Zhongguo Yao Li Xue Bao; 1990 Nov; 11(6):491-4. PubMed ID: 1966653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endogenous natriuretic and ouabain-like factors. Their roles in body fluid volume and blood pressure regulation.
    Kramer HJ; Meyer-Lehnert H; Michel H; Predel HG
    Am J Hypertens; 1991 Jan; 4(1 Pt 1):81-9. PubMed ID: 1848764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitors of Na-K-ATPase in human urine: effects of ouabain-like factors and of vanadium-diascorbate on calcium mobilization in rat vascular smooth muscle cells: comparison with the effects of ouabain, angiotensin II, and arginine-vasopressin.
    Meyer-Lehnert H; Bäcker A; Kramer HJ
    Am J Hypertens; 2000 Apr; 13(4 Pt 1):364-9. PubMed ID: 10821337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypothalamic factor inhibits the (Na,K)ATPase from the extracellular surface. Mechanism of inhibition.
    Carilli CT; Berne M; Cantley LC; Haupert GT
    J Biol Chem; 1985 Jan; 260(2):1027-31. PubMed ID: 2981828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation and characterization of a specific endogenous Na+,K+-ATPase inhibitor from bovine adrenal.
    Tamura M; Lam TT; Inagami T
    Biochemistry; 1988 Jun; 27(12):4244-53. PubMed ID: 2844224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The ATPase activity of saponin-treated rat erythrocytes: regulation by monovalent cations, calcium, ouabain, and furosemide.
    Petrunyaka VV; Panyushkina EA; Severina EP; Orlov SN
    Biochim Biophys Acta; 1990 Dec; 1030(2):279-88. PubMed ID: 2175654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.